BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Javelot H, Michel B, Steiner R, Javelot T, Cottencin O. Zolpidem test and catatonia. J Clin Pharm Ther 2015;40:699-701. [PMID: 26547135 DOI: 10.1111/jcpt.12330] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Beach SR, Gomez-bernal F, Huffman JC, Fricchione GL. Alternative treatment strategies for catatonia: A systematic review. General Hospital Psychiatry 2017;48:1-19. [DOI: 10.1016/j.genhosppsych.2017.06.011] [Cited by in Crossref: 31] [Cited by in F6Publishing: 20] [Article Influence: 6.2] [Reference Citation Analysis]
2 Sienaert P, van Harten P, Rhebergen D. The psychopharmacology of catatonia, neuroleptic malignant syndrome, akathisia, tardive dyskinesia, and dystonia. Handb Clin Neurol 2019;165:415-28. [PMID: 31727227 DOI: 10.1016/B978-0-444-64012-3.00025-3] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
3 Javelot H, Dizet S, Straczek C, Langrée B, Michel B, Haffen E, Bertschy G. Enhancing the role played by clinical pharmacists in psychiatric settings to better integrate clinical psychopharmacology into the decision-making process. Therapie 2021;76:149-56. [PMID: 33358640 DOI: 10.1016/j.therap.2020.12.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Sayadnasiri M, Rezvani F. Treatment of Catatonia in Frontotemporal Dementia: A Lesson From Zolpidem Test. Clin Neuropharm 2019;42:186-7. [DOI: 10.1097/wnf.0000000000000362] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
5 Ungvari GS, Gerevich J, Takács R, Gazdag G. Schizophrenia with prominent catatonic features: A selective review. Schizophr Res 2018;200:77-84. [PMID: 28818505 DOI: 10.1016/j.schres.2017.08.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
6 Breckpot J, Vercruyssen M, Weyts E, Vandevoort S, D'Haenens G, Van Buggenhout G, Leempoels L, Brischoux-Boucher E, Van Maldergem L, Renieri A, Mencarelli MA, D'Angelo C, Mericq V, Hoffer MJ, Tauber M, Molinas C, Castiglioni C, Brison N, Vermeesch JR, Danckaerts M, Sienaert P, Devriendt K, Vogels A. Copy number variation analysis in adults with catatonia confirms haploinsufficiency of SHANK3 as a predisposing factor. Eur J Med Genet 2016;59:436-43. [PMID: 27519580 DOI: 10.1016/j.ejmg.2016.08.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
7 Lucchelli JP, Kourakou S, de Lucia Bové LP, Rodriguez DD. Lorazepam-Resistant Catatonia in an Antipsychotic-Naïve 24-Year-Old with Psychotic Symptoms. Case Rep Psychiatry 2020;2020:2469707. [PMID: 32318305 DOI: 10.1155/2020/2469707] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Delorme C, Adanyeguh I, Bendetowicz D, Le Ber I, Ponchel A, Kas A, Habert MO, Mochel F. Multimodal neurometabolic investigation of the effects of zolpidem on leukoencephalopathy-related apathy. Eur J Neurol 2020;27:2297-302. [PMID: 32757342 DOI: 10.1111/ene.14465] [Reference Citation Analysis]